Skip to main content

Usana Health Sciences Value Stock - Dividend - Research Selection

Usana Health Sciences

ISIN: US90328M1071, WKN: 923145

Market price date: 15.01.2021
Market price: 79,33 USD




Usana Health Sciences Fundamental data and company key figures of the share

Annual reports in USD
Key figures 27-02-2020
Cash flow
Net operating cash flow 126.733.000
Capital Expenditures -16.569.000
Free cash flow 110.164.000
Balance sheet
Total Equity 351.712.000
Liabilities & Shareholders equity 516.934.000
Income statement
Net income 100.526.000
Eps (diluted) 4,410
Diluted shares outstanding 22.795.000
Net sales/revenue 1.060.900.000

Fundamental ratios calculated on: 15-01-2021

Ratios
Key figures 15-01-2021
Cash flow
P/C 14,27
   
P/FC 16,42
Balance sheet
ROI19,45
ROE68,04
Income statement
P/E17,99
Div. Yield0,00%
P/B5,14
P/S1,71


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolUSNA
Market Capitalization1.808.327.296,00 USD
CountryUnited States
IndicesNO INDEX
SectorsPharma
Raw Data SourceUS GAAP in Millionen USD
Stock Split2016-11-23,2.0000/1.0000; 2003-10-31,2.0000/1.0000; 1998-08-04,2.0000/1.0000
Internetwww.usanahealthsciences.com


Description of the company

General

 

USANA Health Sciences, Inc., a Utah corporation, was founded in 1992 by Myron W. Wentz, Ph.D. We develop and manufacture high-quality, science-based nutritional and personal care products with a primary focus on promoting long-term health and reducing the risk of chronic degenerative disease. In so doing, we are committed to continuous product innovation and sound scientific research. We have operations in 19 markets worldwide, where we distribute and sell our products by way of direct selling. We have chosen this distribution method as we believe it is the most conducive to meeting our vision as a company, which is improving the overall health and nutrition of individuals and families around the world. Our net sales in fiscal year 2014 were $790.5 million, of which 81.8% were in markets outside of the United States. As a U.S.-based multi-national company with an expanding international presence, our operating results are sensitive to currency fluctuations, as well as economic and political conditions in markets throughout the world. Additionally, we are subject to the various laws and regulations in the United States, China, and the other markets in which we operate with respect to the products that we sell and to our method of distribution.

 

Our customer base comprises two types of customers: "Associates" and "Preferred Customers." Associates share in our company vision by acting as independent distributors of our products in addition to purchasing our products for their personal use. Preferred Customers purchase our products strictly for personal use and are not permitted to resell or to distribute the products. As of January 3, 2015, we had 349,000 active Associates and 81,000 active Preferred Customers worldwide.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.usanahealthsciences.com